UNSPSC 51101646: Chlorbetamide

This classification denotes an antiprotozoal agent with the molecular formula C11H11Cl4NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3S489RFX0J, chemically known as 2,2-dichloro-n-2,4-dichlorobenzyl-n-2-hydroxyethyl-acetamide but generally known as chlorbetamide, which bears US NIH Compound Identifier 7330. European Medicines Agency schedules Chlorbetamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06177MIG.

UNSPSC 51101646 Chlorbetamide, a Commodity code, shows minimal alignment between the code's nominal scope and recent state and local procurement activity. The single pharmaceutical-focused opportunity tagged to this code—the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products—does not reference chlorbetamide or any herbicide or agricultural chemical family; the RFP solicits finished pharmaceutical products for distribution through authorized wholesalers to state and local government health facilities across participating jurisdictions including Oregon. The three remaining opportunities posted under this code—Seminole County's IFB for naloxone and drug deactivation systems, the Texas HHS Commission's RFI on therapeutic pharmacy direct-to-manufacturer prescriptions, and the City of Tampa's IFB for medical and first aid supplies for fire rescue—are health-focused acquisitions with no connection to the chlorbetamide classification. State and local procurement offices appear to be using this code as a generic tag for pharmaceutical and medical-supply procurement rather than for the specific active ingredient the code nominally describes.

Recent activity clusters in Florida and Minnesota, with exploratory procurement also underway in Texas. Issuing bodies include county health departments (Seminole County), state health and human services agencies (Texas HHS, Minnesota Department of Administration), and municipal purchasing departments (City of Tampa). The MMCAP RFP, due March 26, 2026, represents the largest formal solicitation under the code, seeking manufacturers to supply multiple pharmaceutical products through established wholesaler channels with a two-year initial contract term and optional extensions. Seminole County's IFB (response deadline July 26, 2023, with a posted date of June 30, 2026, suggesting a data anomaly) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. The Tampa Fire Department's medical and first aid supplies IFB (due March 13, 2026, estimated contract value $700,000.00) was designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The code shows no clear, consistent procurement pattern aligned to its nominal herbicide definition and may warrant recategorization or relabeling by state and local procurement offices.